Cure Network Dolby Acceleration Partners LLC

Gabaeron, Inc is a San Francisco-based biotechnology company that specializes in the development of precision medicine and regenerative medicine solutions for neurological disorders. Their innovative approach combines the use of genetically defined apoE genotype-associated neuropathology, regenerative medicine techniques, and pharmaceutical intervention to restore lost neurons and protect against neurodevelopmental disorders. With a focus on Alzheimer's disease and other neurodegenerative diseases, as well as the neurodevelopmental disorder Smith-Lemli-Opitz syndrome, Gabaeron aims to develop first-in-class treatments using human iPSC-derived GABAergic inhibitory interneurons and small molecule drugs. Their groundbreaking research and pipeline projects offer hope for patients by addressing the underlying causes of these disorders and providing potential solutions for neuron replacement and protection.Generated from the website

Gladstone Institutes is an independent biomedical research organization located in San Francisco, dedicated to addressing significant challenges in human health through innovative scientific approaches. With a focus on conditions that have profound medical, economic, and social impacts, Gladstone operates five interconnected institutes that push the boundaries of scientific possibility. Committed to training the next generation of leaders in science, Gladstone fosters a collaborative environment across more than 30 laboratories, emphasizing diversity, equity, and inclusion. The organization actively partners with industry to translate discoveries into real-world therapies, ensuring that scientific advancements benefit society and the economy. Generated from the website

Ilytica is a company located in San Francisco, CA, dedicated to providing innovative solutions in its field. The company is currently enhancing its offerings and invites users to try out a demo of its services. Situated at 1700 Owens Street, Ilytica is focused on delivering quality and efficiency to its clients. With a commitment to progress, the company is in the process of updating its platform to better serve its audience. Generated from the website